Comparison of Parker-Hannifin's Stock Performance to Other Manufacturing Stocks: An Analysis
Parker-Hannifin Corporation, a leading manufacturer and seller of motion and control technologies and systems based in Cleveland, Ohio, has announced its financial results for Q4. The company, which operates through two segments - Diversified Industrial and Aerospace Systems, reported a significant increase in its adjusted net income.
The adjusted net income for Q4 surged 12.2% year-over-year to $992 million. This impressive growth was accompanied by a 1.1% year-over-year increase in net sales, which reached $5.2 billion. Notably, both figures exceeded the consensus estimates by 2.7% and 8.6% respectively.
The strong performance of Parker-Hannifin Corporation has been reflected in the stock market. Since early May, the stock has risen above its 50-day and 200-day moving averages, and on a YTD basis, it has gained 19%. Over the past three months, shares of Parker-Hannifin have gained 13.8%, and following the release of its impressive Q4 results on Aug. 7, they rose 4.1%.
However, as of writing, the stock is trading below the mean price target of $756.96. The current analysis by 23 analysts covering Parker-Hannifin Corporation indicates a "Strong Buy" consensus rating.
Interestingly, the company is strongly dominated by institutional shareholders, owning 90% of the shares, implying significant influence on the stock price. Recent insider selling has been observed, but specific consensus from the analysts on forecasts or ratings was not detailed in the search results as of September 2025.
The stock market sector that Parker-Hannifin Corporation operates in has also shown positive trends. The iShares U.S. Manufacturing ETF (MADE) has a 10.7% increase over the same time frame, and rival Eaton Corporation plc (ETN) has increased 20.6% over the past 52 weeks.
It's worth noting that shares of PH have soared 31.2% over the past 52 weeks, but they have dipped 2.1% from its 52-week high of $773.30.
Disclosure: Kritika Sarmah did not have positions in any of the securities mentioned in this article at the time of publication.
Read also:
- Long-term reinforcement of Dr. Sara Kammann's medical practice
- City Population Decline Correlated with COVID-19 Higher Death Rates
- Sanders' Campaign Advisor Discusses Candidate's Political Standing
- Ebola epidemic unfolds in Democratic Republic of Congo, causing 15 fatalities and initiating World Health Organization's intervention
